Research Article

Preoperative Predictors for 90-Day Mortality after Pancreaticoduodenectomy in Patients with Adenocarcinoma of the Ampulla of Vater: A Single-Centre Retrospective Cohort Study

Table 1

Clinical, laboratory, and operative patient characteristics.

n = 101 (100%)

Patient demographics
Age (y), median (IQR)60 (52–67)
Sex, male : female (count, %)47 (46.5):54 (53.5)
Body mass index (kg/m²), median (IQR)24.6 (21.7–27.5)
MELD score, median (IQR)9 (7–14)
eGFR <90 mL/min/1.73 m², count (%)18 (17.8)

ALBI score (count, %)
ALBI 1 score30 (29.7)
ALBI 2 score46 (45.5)
ALBI 3 score22 (21.8)
Unknown3 (3)

ASA score (count, %)
ASA I2 (2)
ASA II74 (73.3)
ASA III25 (24.8)

Past medical history
Preoperative biliary drainage, count (%)29 (28.7)
Endoscopic18
Percutaneous6
Surgical5
Previous history of cholangitis, count (%)8 (7.9)
Number of RBC packs transfused, median (IQR)0 (0-1)

Preoperative laboratory tests
Haemoglobin (g/L), median (IQR)115 (107–126)
Platelet count (109/L), median (IQR)285 (242–381)
International Normalized Ratio, median (IQR)1.07 (1.02–1.16)
Prothrombin time (sec), median (IQR)12.9 (11.8–14.5)
Serum total bilirubin (µmol/L), median (IQR)22.1 (12–101.4)
Serum glucose (µmol/L), median (IQR)5.1 (4.7–5.6)
Serum creatinine (µmol/L), median (IQR)55 (47–66)
Serum albumin (g/L), median (IQR)37 (32–41)
Serum CA 19-9 (IU/mL), median (IQR)22.2 (9.7–91.4)

Continuous data are expressed as median (IQR). Categorical data are expressed as count (%). Preoperative transfusion.